The man's family later sued OptumRx and Walgreens, claiming they didn't offer alternatives after his regular inhaler's price increased dramatically.
Congressional appropriations package expands reporting obligations for PBMs to increase transparency. It also delinks PBM ...
Centre Daily Times on MSN
Penn State sues insulin makers, health care companies over medication prices
Penn State alleges it has been overcharged millions of dollars since 2008.
With approximately 400 independent pharmacies in Louisiana, many are voicing concern about "unfair" dispensing fees set by ...
Axios on MSN
PBMs hit by Trump transparency rule
Pharmacy benefit managers are facing more pressure after the Department of Labor issued new requirements for disclosing their ...
UnitedHealth Group’s Optum Rx is monitoring three notable drug candidates that might be approved in the next few months, according to its winter 2026 report published Jan. 2. Two of the medications ...
UnitedHealth Group Incorporated is upgraded to Strong Buy due to margin recovery and robust EPS expansion. Learn more about UNH stock here.
Rural independent pharmacies in Colorado continue to struggle as pharmacy benefit managers (PBMs) fail to increase ...
HIV/AIDS activists heralded the approval of a new twice-yearly pre-exposure prophylaxis (PrEP) medication last year, but these celebrations were tempered by insurers’ reluctance to cover its ...
A House committee found that CVS Health may have violated federal antitrust laws by threatening independent pharmacies to ...
In a new lawsuit, Iowa Attorney General Brenna Bird alleges 18 companies have charged Iowans too much for insulin and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results